Sinan Mohammed Abdullah Al-Mahmood

Prof. Dr. Sinan Mohammed Abdullah Al-Mahmood

Pharmacology and Toxicology, University of Tikrit, Tikrīt, Şalāḩ ad Dīn, Iraq
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAbul Azad
Abul Azad
SASinan Mohammed Abdullah Al-Mahmood
Sinan Mohammed Abdullah Al-Mahmood
BCBAPPADITYA CHATTERJEE
BAPPADITYA CHATTERJEE
WSWan Mohd Azizi Wan Sulaiman
Wan Mohd Azizi Wan Sulaiman
TETarek M. Elsayed
Tarek M. Elsayed
Abd Almonem DoolaaneaAbd Almonem Doolaanea
Abd Almonem Doolaanea
Black seed oil (BSO) has been used for various therapeutic purposes around the world since ancient eras. It is one of the most prominent oils used in nutraceutical formulations and daily consumption for its significant therapeutic value is common phenomena. The main aim of this study was to develop alginate-BSO beads as a controlled release system designed to control drug release in the gastrointestinal tract (GIT). Electrospray technology facilitates formulation of small and uniform beads with higher diffusion and swelling rates resulting in process performance improvement. The effect of different formulation and process variables was evaluated on the internal and external bead morphology, size, shape, encapsulation efficiency, swelling rate, in vitro drug release, release mechanism, ex vivo mucoadhesive strength and gastrointestinal tract qualitative and quantitative distribution. All the formulated beads showed small sizes of 0.58 ± 0.01 mm (F8) and spherical shape of 0.03 ± 0.00 mm. The coefficient of weight variation (%) ranged from 1.37 (F8) to 3.93 (F5) ng. All formulations (F1–F9) were studied in vitro for release characteristics and swelling behaviour, then the release data were fitted to various equations to determine the exponent (ns), swelling kinetic constant (ks), swelling rate (%/h), correlation coefficient (r2) and release kinetic mechanism. The oil encapsulation efficiency was almost complete at 90.13% ± 0.93% in dried beads. The maximum bead swelling rate showed 982.23 (F8, r2 = 0.996) in pH 6.8 and the drug release exceeded 90% in simulated gastrointestinal fluid (pH 6.8). Moreover, the beads were well distributed throughout various parts of the intestine. This designed formulation could possibly be advantageous in terms of increased bioavailability and targeted drug delivery to the intestine region and thus may find applications in some diseases like irritable bowel syndrome.

1 August 2021 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AAAbul Kalam Azad
Abul Kalam Azad
Abd Almonem DoolaaneaAbd Almonem Doolaanea
Abd Almonem Doolaanea
SASinan Mohammed Abdullah Al-Mahmood
Sinan Mohammed Abdullah Al-Mahmood
JKJohn F. Kennedy
John F. Kennedy
BCBappaditya Chatterjee
Bappaditya Chatterjee
HBHriday Bera
Hriday Bera

20 September 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SMSaeid Mezail Mawazi
Saeid Mezail Mawazi
SASinan Mohammed Abdullah Al-Mahmood
Sinan Mohammed Abdullah Al-Mahmood
BCBAPPADITYA CHATTERJEE
BAPPADITYA CHATTERJEE
Hazrina HadiHazrina Hadi
Hazrina Hadi
Abd Almonem DoolaaneaAbd Almonem Doolaanea
Abd Almonem Doolaanea
This study aimed to develop a carbamazepine (CBZ) sustained release formulation suitable for pediatric use with a lower risk of precipitation. The CBZ was first prepared as sustained release microparticles, and then the microparticles were embedded in alginate beads, and finally, the beads were suspended in a gel vehicle. The microparticles were prepared by a solvent evaporation method utilizing ethyl cellulose as a sustained release polymer and were evaluated for particle size, encapsulation efficiency, and release profile. The beads were fabricated by the dropwise addition of sodium alginate in calcium chloride solution and characterized for size, shape, and release properties. The gel was prepared using iota carrageenan as the gelling agent and evaluated for appearance, syneresis, drug content uniformity, rheology, release profile, and stability. The microparticles exhibited a particle size of 135.01 ± 0.61 µm with a monodisperse distribution and an encapsulation efficiency of 83.89 ± 3.98%. The beads were monodispersed with an average size of 1.4 ± 0.05 mm and a sphericity factor of less than 0.05. The gel was prepared using a 1:1 ratio (gel vehicle to beads) and exhibited no syneresis, good homogeneity, and good shear-thinning properties. The release profile from the beads and from the gel was not significantly affected, maintaining similarity to the tablet form. The gel properties were maintained for one month real time stability, but the accelerated stability showed reduced viscosity and pH with time. In conclusion, CBZ in a gel sustained release dosage form combines the advantages of the suspension form in terms of dosing flexibility, and the advantages of the tablet form in regards to the sustained release profile. This dosage form should be further investigated in vivo in animal models before being considered in clinical trials.
1

11 July 2016 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
SASinan Mohammed Abdullah Al-Mahmood
Sinan Mohammed Abdullah Al-Mahmood
SAShahrin Tarmizi Bin Che Abdullah
Shahrin Tarmizi Bin Che Abdullah
NANik Nur Fatnoon Nik Ahmad
Nik Nur Fatnoon Nik Ahmad
AMAbdul Hadi Bin Mohamed
Abdul Hadi Bin Mohamed
TRTariq Abdul Razak
Tariq Abdul Razak
Purpose: To evaluate synergy in the analgesic effects of a combination therapy of carbamazepine (CBZ) and gabapentin (GBP) in diabetic neuropathic pain. Methods: Neuropathic pain was produced in rats by a single intraperitoneal injection of streptozotocin (STZ) at 60 mg/kg. CBZ, GBP, and their combination were orally administered at varying doses (GBP 30 - 180 mg/kg; CBZ 20 - 40 mg/kg) comparable to their therapeutic doses in humans. Nociceptive responses in the diabetic rats were assessed using hot plate test. Results: Hot plate latency significantly increased with oral administration of GBP at a dose of 180 mg/kg when compared with control group (p < 0.05), while at a dose of 90 mg/kg, the increase was not significant. Oral administration of CBZ at doses of 20 and 40 mg/kg did not produce any significant impact on hot plate latency. However, a combination of GBP at 90 mg/kg and CBZ at 20 mg/kg produced significant increase in latency, compared with control group and other groups (p < 0.05), except the group that received 180 mg/kg GBP. The combination of low dose GBP 30 mg/kg and carbamazepine 30 mg/kg had no significant effect on latency (p > 0.05). Conclusion: The results obtained in this study provide useful information on the combination therapy of GBP and CBZ, which may be applied in the treatment of pain in diabetic neuropathy. Keywords: Diabetic neuropathy, Carbamazepine, Gabapentin, Hot-plate test

15 February 2018 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
SASinan Mohammed Abdullah Al-Mahmood
Sinan Mohammed Abdullah Al-Mahmood
TRTariq Abdul Razak
Tariq Abdul Razak
NANik Nur Fatnoon Nik Ahmad
Nik Nur Fatnoon Nik Ahmad
AMAbdul Hadi Bin Mohamed
Abdul Hadi Bin Mohamed
SAShahrin Tarmizi Bin Che Abdullah
Shahrin Tarmizi Bin Che Abdullah
Purpose: To evaluate the quality of life of patients with peripheral diabetic neuropathy pain (PDNP) in Hospital Tegku Ampaun Afzan (HTAA), Kuantan, Malaysia. Methods: Ninety (90) participants were selected from the Medical Outpatient Department (MOPD) clinic of HTAA. The study adopted a cross-sectional design, and the self-administered Douleur Neuropathy 4 (DN4) and Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaires were used for data collection. Results: The negative impact of diabetes on QoL was clearly reflected in the fact that every domain had a negative mean value. Overall, 27.8 % of the participants reported that DM negatively affected their QoL and 37.8 % expressed the opinion that their QoL would have been higher if they were not diabetic. QoL correlated with marital status and age, with married participants and participants in the age range 50 - 59 years old showing QoL negatively affected (p < 0.05) by DM with PDNP. Apart from diabetes type, all other characteristics significantly affected participants QoL as reflected by the various related domains (p < 0.05). Conclusion: Based on the findings of this study, it seems that individuals with diabetes and PDNP have a low QoL, with regard to “freedom to eat”, “freedom to drink”, “physical health”, “family life”, and “living condition”. Keywords: Quality of life, Diabetes, Peripheral neuropathy pain

1 September 2017 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
IAImad M Al-Ani
Imad M Al-Ani
SISoraya Ismail
Soraya Ismail
KMKhin M Maung
Khin M Maung
POPakeer Oothuman
Pakeer Oothuman
SASinan Mohammed Abdullah Al-Mahmood
Sinan Mohammed Abdullah Al-Mahmood
Objective: Tamarind (Tamarindus indica) has been used as a medical plant for treating many human and animal diseases and widely used as a traditional herbal medicine for the treatment of snake bites. The objective of the study is to investigate whether tamarind seed extract (TSE) has neutralization activity on an adverse histological reaction against venoms of the King Cobra.Methods: A total of 20 healthy mature male mice were randomly divided into 4 groups with 5 mice in each. The control group was injected with 1 ml of normal saline. The second group was injected subcutaneously with a single dose of 24.96 μg/20 g King Cobra venom (KCV) solution. The third group was injected with the same dose of KCV solution and 10 mg/20 g of TSE. The fourth group was injected with the same dose of KCV solution and 15 mg/20 g TSE solution. The animals were sacrificed after 24 hrs of injection of the solution. Fragments of muscle, kidney, and liver were fixed in 10% neutral buffered formalin and processed for light microscopical studies.Results: The result showed that TSE reduced the histopathological changes induced by the KCV in the muscles, livers, and kidneys, and the improvement was proportional to the applied dose of the TSE indicating that TSE prevents adverse histological changes in the muscle, liver, and kidney.Conclusion: The present study demonstrated that TSE reduced the histopathological changes in the muscle, liver, and kidney induced by KCV in mice.